Extended Duration Myostatin Antibody for Enhanced Weight Loss Quality
- Extended half-life reduces dosing frequency and injection volume and improves patient experience
- Myostatin inhibition can minimise lean mass loss during weight loss on GLP-1s
- Precision targeting of additional TGF-beta superfamily members could enable further improvements in weight loss quality